Medicalgorithmics S.A.

Equities

MDG

PLMDCLG00015

Advanced Medical Equipment & Technology

Market Closed - Warsaw S.E. Other stock markets 11:55:55 2024-05-15 am EDT			5-day change	1st Jan Change
26.04 ^PLN	-0.84%		+0.39%	-14.76%

Apr. 22	Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Medicalgorithmics S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Medicalgorithmics healthcare Reports Earnings Results for the Third Quarter 2018

November 20, 2018 at 01:50 pm EST

Medicalgorithmics healthcare reported earnings results for the third quarter 2018. For the quarter, the company reported Revenues of PLN 48.8 million. EBIT was PLN 3.5 million. Net attributable was PLN 1.8 million.

Latest news about Medicalgorithmics S.A.

Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 22	CI
Medicalgorithmics S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 29	CI
Medicalgorithmics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-09-28	CI
Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Medicalgorithmics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
Bio Fund Management Ltd. signed an agreement to acquire 100% stake in Kardiolytics Inc. for $44.9 million.	22-10-02	CI
Medicalgorithmics S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-29	CI
Medicalgorithmics S.A. Secures FDA Approval for DeepRhytmAI Technology	22-08-10	CI
Medicalgorithmics S.A. announced a financing transaction	22-06-02	CI
Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Medicalgorithmics to Consider Finding Investor for Group, Sale of Significant Assets	22-02-04	CI
Rafal Brzoska Withdrawn from Negotiations with Medicalgorithmics	22-01-21	CI
Medicalgorithmics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Medicalgorithmics S.A. announced that it expects to receive PLN 15.58017 million in funding	21-11-14	CI
Medicalgorithmics Starts Talks with Rafal Brzoska on Acquisition of Company's Shares	21-10-26	CI
Medicalgorithmics S.A. Reports Earnings Results for the Second Quarter 2021	21-10-01	CI
Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-25	CI
Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-01	CI
Medicalgorithmics S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-24	CI
Medicalgorithmics S.A. Announces Earnings Guidance for the Third Quarter of 2020	20-08-27	CI
Medicalgorithmics Reports Earnings Results for 2019	20-04-30	CI
Undisclosed buyers acquired unknown stake in Medicalgorithmics S.A..	20-03-02	CI
Medicalgorithmics healthcare Reports Earnings Results for the Third Quarter 2018	18-11-20	CI
Medicalgorithmics S.A. Names Peter G. Pellerito as CEO of the US Unit Medi-Lynx	18-10-16	CI

Chart Medicalgorithmics S.A.

Duration

Period

More charts

Company Profile

Medicalgorithmics SA is a Poland-based company engaged in the advanced medical equipment and technology industry. The Company develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). It operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-20 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
MEDICALGORITHMICS S.A.	-14.76%	66.19M
SARTORIUS AG	-12.09%	19.25B
QUIDELORTHO CORPORATION	-38.57%	2.96B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+22.02%	1.96B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.62%	1.69B
BIOTAGE AB	+33.51%	1.27B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.17%	982M
CONTEC MEDICAL SYSTEMS CO.,LTD	-22.01%	913M
REVENIO GROUP OYJ	+5.38%	801M
VAREX IMAGING CORPORATION	-24.10%	630M

Medical Diagnostic & Testing Equipment